[1] |
辛军,周金,欧阳永娥,等.Survivin和Ki-67在肾癌中的表达及其临床意义[J].现代泌尿生殖肿瘤杂志,2014,6(2):98-101.
|
[2] |
Hari DM,Leung AM,Lee JH,et al.AJCC Cancer Staging Manual 7th edition criteria for colon cancer: do the complex modifications improve prognostic assessment?[J].J Am Coll Surg,2013,217(2):181-190.
|
[3] |
孙燕,王凡.Vimentin在肾透明细胞癌中的表达及临床意义[J].现代肿瘤医学,2015,23(20):2990-2993.
|
[4] |
谢金玲,卓少元.Vimentin在原发性肝癌发生发展及凋亡过程中的作用[J].中国肿瘤,2017,26(2):130-134.
|
[5] |
Ivaska J, Pallari HM, Nevo J, et al.Novel functions of vimentin in cell adhesion, migration, and signaling[J].Exp Cell Res, 2007,313(10):2050-2062.
|
[6] |
Gawlitta W,Osborn M,Weber K.Coiling of intermediate filaments induced by microinjection of a vimentin-specific antibody does not interfere with locomotion and mitosis[J].Eur J Cell Biol, 1981,26(1):83-90.
|
[7] |
Lindsay CR, Le Moulec S, Billiot F, et al.Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer[J].BMC Cancer, 2016(16):168.
|
[8] |
Holthöfer H, Miettinen A, Paasivuo R, et al.Cellular origin and differentiation of renal carcinomas.A fluorescence microscopic study with kidney-specific antibodies, antiintermediate filament antibodies, and lectins[J].Lab Invest, 1983,49(3):317-326.
|
[9] |
Polioudaki H, Agelaki S, Chiotaki R, et al.Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer[J].BMC Cancer, 2015(15):399.
|
[10] |
万安,周颖,曲皖君,等.子宫颈癌中vimentin和ki-67蛋白表达及其影响因素分析[J].中华疾病控制杂志,2014,18(9):805-807.
|
[11] |
Lawrence NF, Hammond MR, Frederick DT, et al.Ki-67, p53,and p16 expression,and G691S RET polymorphism in desmoplastic melanoma (DM): a clinicopathologic analysis of predictors of outcome[J].J Am Acad Dermatol, 2016,75(3):595-602.
|
[12] |
Gerdes J, Lemke H, Baisch H, et al.Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67[J].J Immunol,1984,133(4):1710-1715.
|
[13] |
吕旭,姜叶娟,王香,等.p53与Ki-67在胃癌组织中表达与淋巴转移的关系[J].中华疾病控制杂志,2015,19(4):407-410.
|
[14] |
娄雪玲,周梅玲,张占薪,等.雌激素受体、孕激素受体、C-erbB-2和Ki-67在子宫内膜癌中的表达及其与临床病理相关性[J].中国实用妇科与产科杂志,2014(7):557-560.
|
[15] |
郭云娣,张雅琴,白光辉.APE1和Ki67蛋白在胃癌组织中的表达及其临床意义[J].江苏医药,2012(19):2290-2292.
|
[16] |
Nakajima M,Sawada H,Yamada Y,et al.The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas[J].Cancer, 1999,85(9):1894-1902.
|
[17] |
Bouzubar N, Walker KJ, Griffiths K, et al.Ki67 immunostaining in primary breast cancer: pathological and clinical associations[J].Br J Cancer, 1989,59(6):943-947.
|
[18] |
Carreras R, Alameda F, Mancebo G, et al.A study of Ki-67,c-erbB2 and cyclin D-1 expression in CIN-Ⅰ,CIN-Ⅲ and squamous cell carcinoma of the cervix[J].Histol Histopathol, 2007,22(6):587-592.
|
[19] |
杨映红,林明稀,郑宇辉,等.分化抑制蛋白Id1和PCNA及Ki67在肝细胞癌中的表达及意义[J].中国肿瘤临床与康复,2008,15(1):30-32.
|